06 / Bioprocess
Published reporting, research and funding records filed under Bioprocess.
12 August 2026 · Manufacturing · Funding · Bioprocess
Believer Meats’ Israeli trustee has lengthened the bidding period for the insolvent cultivated-meat company’s patents and production know-how as a separate sale advances for its North Carolina factory.
12 August 2026 · Cultivated meat · Manufacturing · Funding · Bioprocess
AgFunderNews reports that Believer Meats’ Israeli trustee has lengthened bidding for its cultivated-meat patents and know-how, while a separate court-led sale advances for the company’s North Carolina production facility.
12 August 2026 · Regulation · Bioprocess
The Good Food Institute is convening two virtual cultivated-seafood workshops to compare technical barriers, nutrition questions and cell-line collaboration while gathering researcher feedback on its PICES database.
12 August 2026 · Cultivated meat · Manufacturing · Bioprocess
A South Korean university study examined a soil-fungus polysaccharide as a cultivated-beef culture aid, reporting benefits during cell expansion and muscle formation while leaving important commercial questions unanswered.
12 August 2026 · Cultivated meat · Regulation · Manufacturing · Funding · Bioprocess
BeneMeat brought Czech meat-sector representatives inside its pilot facility to discuss cultivated-cell production, labeling and adoption, presenting incumbent processors as prospective customers rather than competitors.
5 August 2026 · Fermentation · Regulation · Manufacturing · Funding · Bioprocess
Australian precision-fermentation company All G has entered the US lactoferrin market with an iron-depleted bovine-equivalent protein, pairing commercial production claims with a strategy aimed at nutrition and supplement formulators.
4 August 2026 · Cultivated meat · Manufacturing · Funding · Bioprocess
A patent roundup highlights how Hanwha Solutions, Tufts University and IamFluidics are addressing culture-medium expense and cell-recovery losses, while leaving commercial-scale performance and patent outcomes unsettled.